Ray Dalio’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.12M | Buy |
14,487
+12,801
| +759% | +$6.95M | 0.03% | 335 |
|
|
2025
Q4 | $977K | Buy |
+1,686
| New | +$953K | ﹤0.01% | 893 |
|
|
2024
Q3 | – | Sell |
-33,729
| Closed | -$18.7M | – | 923 |
|
|
2024
Q2 | $18.7M | Buy |
+33,729
| New | +$19.3M | 0.1% | 162 |
|
|
2023
Q4 | – | Sell |
-42,085
| Closed | -$21.3M | – | 809 |
|
|
2023
Q3 | $21.3M | Sell |
42,085
-41,562
| -50% | -$22.1M | 0.13% | 128 |
|
|
2023
Q2 | $43.6M | Sell |
83,647
-11,970
| -13% | -$6.46M | 0.27% | 76 |
|
|
2023
Q1 | $55.1M | Sell |
95,617
-6,975
| -7% | -$3.93M | 0.34% | 60 |
|
|
2022
Q4 | $56.5M | Sell |
102,592
-38,541
| -27% | -$20.4M | 0.31% | 70 |
|
|
2022
Q3 | $71.6M | Buy |
141,133
+79,441
| +129% | +$44.5M | 0.36% | 57 |
|
|
2022
Q2 | $33.5M | Sell |
61,692
-74,057
| -55% | -$40.8M | 0.14% | 136 |
|
|
2022
Q1 | $80.2M | Buy |
135,749
+89,233
| +192% | +$51.3M | 0.32% | 55 |
|
|
2021
Q4 | $31M | Buy |
46,516
+37,737
| +430% | +$23.6M | 0.18% | 98 |
|
|
2021
Q3 | $5.02M | Buy |
+8,779
| New | +$4.82M | 0.03% | 291 |
|
|
2020
Q2 | – | Sell |
-12,913
| Closed | -$3.66M | – | 505 |
|
|
2020
Q1 | $3.66M | Buy |
+12,913
| New | +$4.07M | 0.07% | 80 |
|
|
2018
Q4 | – | Sell |
-6,418
| Closed | -$1.57M | – | 515 |
|
|
2018
Q3 | $1.57M | Sell |
6,418
-13,274
| -67% | -$3.05M | 0.02% | 193 |
|
|
2018
Q2 | $4.08M | Buy |
+19,692
| New | +$4.18M | 0.04% | 152 |
|
|
2017
Q3 | – | Sell |
-10,194
| Closed | -$1.78M | – | 387 |
|
|
2017
Q2 | $1.78M | Buy |
10,194
+1,350
| +15% | +$227K | 0.02% | 171 |
|
|
2017
Q1 | $1.36M | Sell |
8,844
-19,856
| -69% | -$3.03M | 0.02% | 174 |
|
|
2016
Q4 | $4.05M | Buy |
28,700
+18,100
| +171% | +$2.67M | 0.04% | 150 |
|
|
2016
Q3 | $1.69M | Sell |
10,600
-1,866
| -15% | -$288K | 0.02% | 197 |
|
|
2016
Q2 | $1.84M | Buy |
+12,466
| New | +$1.84M | 0.02% | 200 |
|
|
2015
Q4 | – | Sell |
-30,504
| Closed | -$3.73M | – | 406 |
|
|
2015
Q3 | $3.73M | Sell |
30,504
-13,219
| -30% | -$1.72M | 0.05% | 159 |
|
|
2015
Q2 | $5.67M | Buy |
+43,723
| New | +$5.7M | 0.05% | 92 |
|
|
2015
Q1 | – | Sell |
-11,899
| Closed | -$1.49M | – | 393 |
|
|
2014
Q4 | $1.49M | Buy |
+11,899
| New | +$1.45M | 0.01% | 219 |
|
|
2014
Q2 | – | Sell |
-42,130
| Closed | -$5.07M | – | 367 |
|
|
2014
Q1 | $5.07M | Buy |
+42,130
| New | +$5.01M | 0.04% | 98 |
|
Other funds holding TMO
VCM
Ray Dalio's TMO Position: Q1 2026 in Review
Ray Dalio increased its Thermo Fisher Scientific (TMO) stake by 759% in Q1 2026, buying an estimated $6.95M and bringing the position to 14,487 shares worth $7.12M. The position accounts for 0.03% of the portfolio, ranked #335.
Ray Dalio first reported a position in TMO in Q1 2014 and has held it in 24 quarters since. The position peaked at $80.2M in Q1 2022. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Ray Dalio held 14,487 shares of Thermo Fisher Scientific worth $7.12M as of Q1 2026.
- Ray Dalio bought 12,801 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.95M.
- Thermo Fisher Scientific made up 0.03% of Ray Dalio's portfolio in Q1 2026, its #335 holding.
- Ray Dalio first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 24 quarters since.
- Ray Dalio's Thermo Fisher Scientific position peaked at $80.2M in Q1 2022.
- 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.